View in EDS

Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial.

Saved in:
Bibliographic Details
Title: Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial.
Authors: Gamborg M; Cancer and Medicine, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark., Grand MK; Statistics and Data Analysis, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark., Grell K; Statistics and Data Analysis, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark., Rosthøj S; Statistics and Data Analysis, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark., Pedersen-Bjergaard U; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Endocrine Section, Department of Endocrinology and Nephrology, Nordsjaellands Hospital, Hilleroed, Denmark., Torp-Pedersen C; Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Nordsjaellands Hospital, Hilleroed, Denmark., Mørch LS; Cancer and Medicine, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
Source: The Lancet regional health. Europe [Lancet Reg Health Eur] 2025 Jun 14; Vol. 55, pp. 101346. Date of Electronic Publication: 2025 Jun 14 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-7762
DOI:10.1016/j.lanepe.2025.101346